Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Zealand Pharma A/S

Recent news which mentions Zealand Pharma A/S

Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags LILLY DRN Zealand Pharma A/S Pharmaceuticals
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Augmedix Inc Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Roche Holding AG Breaking News: Markets Eli Lilly and Co
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Viking Therapeutics Inc
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe Markets Zealand Pharma A/S Pharmaceuticals
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Zealand Pharma A/S Exchange/traded funds Eli Lilly and Co
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Amgen Inc Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags GE HealthCare Technologies Inc Health & Science 89Bio Inc
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Breaking News: Markets Zealand Pharma A/S Pharmaceuticals
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Pharmaceuticals Business Bayer AG
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.